remdesivir

A broad-spectrum antiviral drug originally developed for hepatitis C and Ebola, now under WHO-sponsored trial alongside MBP134 for Bundibugyo ebolavirus pending DRC and Uganda regulatory approval.

1 of 1 entries (1 events, 0 interactions)